Xcout IntelSign inSubscribe

Arcadia Biosciences, Inc.

RKDABiotechnologyDavis, TX, United States

Arcadia Biosciences, Inc. is a U.S.-based company that provides plant-derived health and well-being products. Additionally, it is actively engaged in agricultural research and development, with a particular focus on improving wheat crops. The aim of these innovations is to enhance farmers' economic stability by boosting crop performance in the field, increasing their value for food and wellness applications, and expanding their potential for industrial uses. Established in 2002, the company's main office is located in Davis, California.

Subscribe to see Arcadia Biosciences, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

Arcadia Biosciences, Inc. at a glance

Arcadia Biosciences, Inc. is a biotechnology company headquartered in Davis, United States. It is publicly listed (RKDA) with a market capitalisation of $1.3M. Xcout tracks 12 named people at Arcadia Biosciences, Inc., including Thomas J. Schaefer (CEO, Interim CFO, Principal Accounting Officer, President, Corporate Secretary & Director).

As of 16 November 2026. Source: Xcout Intel.

Industry
Biotechnology
Headquarters
Davis, TX, United States
Market cap
$1.3M
Employees
9
Ticker
RKDA

Arcadia Biosciences, Inc. leadership

  • Thomas J. SchaeferCEO, Interim CFO, Principal Accounting Officer, President, Corporate Secretary & Director
  • T.J. SchaeferPresident and Chief Executive Officer
  • Thomas J. SchaeferExecutive Officer
  • Albert D. BollesDirector
  • Amy D YoderDirector
  • Amy YoderDirector

6 more named people on record for Arcadia Biosciences, Inc., with roles, board committees and tenure — see the full roster →

Arcadia Biosciences, Inc. funding rounds on record

The 2 most recent:

DateRoundAmountInvestors
Series D$33M1 named
Grant$2M1 named

Some filings are not shown as funding rounds.

Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →

Who funded each Arcadia Biosciences, Inc. round

A funding-flow diagram of the 7 named investors across 4 rounds: who backed which round, who led it, and who came back for the next one.

Sign in to see it, or subscribe for the full funding history →

Who owns Arcadia Biosciences, Inc.

16 institutions reported a position for the quarter ending 30 June 2026, and 2 insiders hold at least 0.1% of the shares.

Hrt Financial: 3.70%Citadel: 1.00%Virtu Financial: 0.90%Geode Capital: 0.70%XTX Topco: 0.60%Other institutions: 1.90%Other insiders: 0.20%Not held by 13F institutions or listed insiders: 91.00%Arcadia Bioscienc…8.8%held byinstitutions
Ownership of Arcadia Biosciences, Inc. by 13F institution and insider
Holder% of shares outstanding
Hrt Financial3.70%
Citadel1.00%
Virtu Financial0.90%
Geode Capital0.70%
XTX Topco0.60%
Other institutions1.90%
Other insiders0.20%
Not held by 13F institutions or listed insiders91.00%
  1. 1Hrt FinancialHRT FINANCIAL LP3.7%
  2. 2CitadelCITADEL ADVISORS LLC1.0%
  3. 3Virtu FinancialVirtu Financial LLC0.9%
  4. 4Geode CapitalGEODE CAPITAL MANAGEMENT, LLC0.7%
  5. 5XTX TopcoXTX Topco Ltd0.6%

The full list of 16 institutions, with share counts and what each bought or sold since the previous quarter.

Sign in to see it, or subscribe →

Source: SEC Form 13F filings, period ending 30 June 2026; shares outstanding from the company's 10-Q as of 6 August 2026. 13F covers the US-listed holdings of investment managers with more than $100 million under management and is filed up to 45 days after the quarter ends. A firm that files under several names (Vanguard files as two managers) is one row, with its filers listed under it. Individuals are company insiders (directors, officers and 10% owners) holding at least 0.1% of the shares, from their latest SEC Form 3, 4 or 5 (newest 5 February 2025), counting shares held directly and through trusts and other entities they report, including high-vote class shares (such as Class B); options and restricted stock units are not counted. They are a separate slice from the 13F institutions, so the ring adds up to 100%: what is left is held by smaller insiders, retail investors and anyone else who does not file.

Investors

Arcadia Biosciences, Inc. competitors

A few of Arcadia Biosciences, Inc.'s closest competitors — see the full list of competitors and alternatives →

Codexis, Inc.CDXS · BiotechRedwood City, CA, United States
66% matchPublic

Codexis, Inc. is a biotechnology firm dedicated to the discovery, development, and commercialization of enzymes and other protein-based solutions. Its diverse portfolio encompasses advanced biocatalyst products and related services, specialized chemical intermediates vital for subsequent processing steps, and proprietary biocatalyst panels and kits that empower clients to conduct effective chemistry screening. The company also extends its expertise through biocatalyst screening and sophisticated protein engineering services. Central to its operations is the proprietary CodeEvolver protein engineering technology platform. This innovative platform is instrumental in crafting and delivering high-performance biocatalysts capable of driving chemical transformations, thereby significantly enhancing the efficiency and productivity of manufacturing processes. Beyond industrial applications, the CodeEvolver platform is also leveraged for identifying novel biotherapeutic drug candidates for targeted human diseases, as well as for developing enzymes essential for molecular biology research and in vitro diagnostic applications. Primarily serving pharmaceutical manufacturers, Codexis distributes its products through its dedicated direct sales and business development teams across the United States and Europe. Established in 2002, the company maintains its headquarters in Redwood City, California.

Market cap$104.9M
Employees188
Codexis, Inc. competitors & alternatives →

Get Arcadia Biosciences, Inc.'s news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Something wrong or missing about Arcadia Biosciences, Inc.? Suggest a correction · Work at Arcadia Biosciences, Inc.? Claim this profile

Is this your company? Add the Xcout Intel badge to your website

Free, for any company on Xcout Intel. It links visitors to this profile.

Arcadia Biosciences, Inc. on Xcout Intel

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

Arcadia Biosciences, Inc. — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on Arcadia Biosciences, Inc. in Xcout Intel

  • 12 named people with titles, LinkedIn and board committees
  • 4 funding rounds with the investors in each, and who they co-invest with
  • 5 corporate events with sources — deals, leadership changes, layoffs
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →